PH30152A - Apoptosis regulating composition - Google Patents
Apoptosis regulating compositionInfo
- Publication number
- PH30152A PH30152A PH46711A PH46711A PH30152A PH 30152 A PH30152 A PH 30152A PH 46711 A PH46711 A PH 46711A PH 46711 A PH46711 A PH 46711A PH 30152 A PH30152 A PH 30152A
- Authority
- PH
- Philippines
- Prior art keywords
- regulating composition
- apoptosis regulating
- apoptosis
- composition
- regulating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22037392 | 1992-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH30152A true PH30152A (en) | 1997-01-21 |
Family
ID=16750110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH46711A PH30152A (en) | 1992-08-19 | 1993-08-18 | Apoptosis regulating composition |
Country Status (8)
Country | Link |
---|---|
US (2) | US5464833A (ar) |
EP (1) | EP0623598A4 (ar) |
AU (1) | AU666577B2 (ar) |
CA (1) | CA2121148A1 (ar) |
MX (1) | MX9305056A (ar) |
PH (1) | PH30152A (ar) |
TW (1) | TW240168B (ar) |
WO (1) | WO1994004504A1 (ar) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU672288B2 (en) * | 1993-03-02 | 1996-09-26 | Akira Matsumori | Rejection inhibitor for transplants and IL-1 production inhibitor |
US5497913A (en) * | 1993-12-15 | 1996-03-12 | Denny D. Baker | Mixing bag arrangement and method |
WO1995033070A1 (en) * | 1994-05-26 | 1995-12-07 | New York Medical College | Detection of halogenated precursors incorporated into dna |
US5504093A (en) * | 1994-08-01 | 1996-04-02 | Otsuka Pharmaceutical Co., Ltd. | Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication |
CA2158822C (en) * | 1994-09-27 | 2008-12-23 | Kusuki Nishioka | Therapeutic agent for rheumatic disease |
US5620888A (en) * | 1994-12-29 | 1997-04-15 | Lxr Biotechnology, Inc. | Cell strains for use in identifying potentially therapeutically effective agents |
US5571523A (en) * | 1995-03-09 | 1996-11-05 | President And Fellows Of Harvard College | Antioxidant-induced apoptosis in vascular smooth muscle cells |
WO1998046229A1 (fr) * | 1995-06-21 | 1998-10-22 | Otsuka Pharmaceutical Co., Ltd. | Inhibiteurs de la production d'il-8 et du mcaf |
WO1997008345A1 (en) * | 1995-08-30 | 1997-03-06 | New York Medical College | Methods for labeling dna ends with halogenated nucleotides and detecting same with antibodies |
US5846758A (en) * | 1995-11-30 | 1998-12-08 | His Excellency Ghassan I. Shaker | Method for diagnosing autoimmune diseases |
US5780480A (en) * | 1996-02-28 | 1998-07-14 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
WO1997031910A1 (en) * | 1996-02-28 | 1997-09-04 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5912168A (en) * | 1996-08-30 | 1999-06-15 | Genesis Research & Development Corporation Limited | CD95 regulatory gene sequences |
US20020151063A1 (en) * | 1996-08-30 | 2002-10-17 | Annette Lasham | Methods for modulating apoptotic cell death |
US6180402B1 (en) | 1996-11-20 | 2001-01-30 | Qlt Inc. | Method for inhibiting apoptosis induced by photodynamic therapy using a cysteine or serine protease inhibitor |
AU6854398A (en) * | 1997-04-25 | 1998-11-24 | Otsuka Pharmaceutical Co., Ltd. | Hyaluronate synthesis inhibitors |
TWI244484B (en) * | 1998-06-09 | 2005-12-01 | Takara Bio Inc | Pharmaceutical composition containing oxy-containing hexacyclic compound |
ATE276763T1 (de) | 1998-07-13 | 2004-10-15 | Univ Texas | Verwendung von antikörper gegen aminophospholipide zur krebsbehandlung |
SI1107795T1 (en) | 1998-09-04 | 2003-06-30 | The Regents Of The University Of Michigan | Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis |
AU5877500A (en) * | 1999-06-15 | 2001-01-02 | Neurogen Corporation | Piperidinyl and piperazinyl substituted benzofused lactams |
US6254888B1 (en) | 2000-01-28 | 2001-07-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for coating pharmaceutical dosage forms |
EP1404329A4 (en) * | 2001-06-04 | 2006-11-02 | Cytovia Inc | QUINOLINONES 4-ARYL-3- (3-ARYL-1-OXO-2-PROPENYL) -2 (1H) -US SUBSTITUTED, AND ANALOGUES AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS, AND RELATIVE USE |
GB0124848D0 (en) * | 2001-10-16 | 2001-12-05 | Celltech R&D Ltd | Chemical compounds |
WO2003038060A2 (en) * | 2001-11-01 | 2003-05-08 | The Regents Of The University Of Michigan | Small molecule inhibitors targeted at bcl-2 |
US20040014744A1 (en) * | 2002-04-05 | 2004-01-22 | Fortuna Haviv | Substituted pyridines having antiangiogenic activity |
PT1537146E (pt) | 2002-07-15 | 2011-03-15 | Boards Of Regents The University Of Texas System | Anticorpos ligantes a fosfolípidos aniónicos e aminofosfolípidos, e sua utilização no tratamento de infecções virais |
WO2008109433A2 (en) | 2007-03-02 | 2008-09-12 | The Cleveland Clinic Foundation | Anti-angiogenic peptides |
KR101395370B1 (ko) | 2004-01-22 | 2014-05-14 | 유니버시티 오브 마이애미 | 국소용 코-엔자임 큐10 제형 및 그의 사용 방법 |
US8034905B2 (en) | 2007-11-09 | 2011-10-11 | Affitech Research, AS | Anti-VEGF antibody compositions and methods |
GB2532990A (en) | 2014-12-05 | 2016-06-08 | Schlumberger Holdings | Corrosion inhibition |
GB2543498A (en) * | 2015-10-19 | 2017-04-26 | Schlumberger Holdings | Corrosion inhibition |
CN107174584B (zh) * | 2016-03-12 | 2020-09-01 | 福建金乐医药科技有限公司 | 含哌嗪结构化合物在制备lsd1抑制剂中的应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2931741A1 (de) * | 1979-08-04 | 1981-02-26 | Thomae Gmbh Dr K | Arzneimittel zur vermeidung von tumormetastierung |
JPS6038384B2 (ja) * | 1978-03-24 | 1985-08-31 | 大塚製薬株式会社 | チオセミカルバゾン誘導体 |
JPS5742673A (en) * | 1980-08-29 | 1982-03-10 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
JPS5777676A (en) * | 1980-10-31 | 1982-05-15 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
JPS5883677A (ja) * | 1981-11-11 | 1983-05-19 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
JPS5929667A (ja) * | 1982-08-13 | 1984-02-16 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体および強心剤 |
JPS59104378A (ja) * | 1982-12-03 | 1984-06-16 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
US4677112A (en) * | 1984-02-02 | 1987-06-30 | Warner-Lambert Company | 1,2,3,4-tetrahydro-2-oxo-8-quinolineacetic and -propanoic acids and derivatives as cognition activators |
US4582909A (en) * | 1984-02-02 | 1986-04-15 | Warner-Lambert Company | Benzobicyclic lactam acids and derivatives as cognition activators |
US4760064A (en) * | 1984-12-18 | 1988-07-26 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril compounds, compositions containing same and processes for preparing same |
JPH07100696B2 (ja) * | 1984-12-18 | 1995-11-01 | 大塚製薬株式会社 | カルボスチリル誘導体 |
DE3526044A1 (de) * | 1985-07-20 | 1987-01-22 | Hoechst Ag | Dihydrochinolinon-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung, sowie zwischenprodukte zu ihrer herstellung |
JPS62135423A (ja) * | 1985-12-09 | 1987-06-18 | Otsuka Pharmaceut Co Ltd | 低酸素症改善剤 |
DK588486A (da) * | 1985-12-09 | 1987-06-10 | Otsuka Pharma Co Ltd | Anvendelse af en forbindelse til behandling af hypoxi |
JPS63225357A (ja) * | 1987-03-12 | 1988-09-20 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
US5185346A (en) * | 1988-11-29 | 1993-02-09 | Hanssen Pharmaceutica | (1H-azol-1-ylmethyl)substituted quinoline derivatives |
TW201305B (ar) * | 1991-04-03 | 1993-03-01 | Otsuka Pharma Co Ltd | |
DK0552373T3 (da) * | 1991-07-03 | 1999-12-27 | Otsuka Pharma Co Ltd | Apoptoseregulator |
JPH05320133A (ja) * | 1991-07-18 | 1993-12-03 | Japan Tobacco Inc | 3,4−ジヒドロ−2(1h)−キノリノン誘導体 |
JP2597953B2 (ja) * | 1991-12-10 | 1997-04-09 | 大塚製薬株式会社 | 制癌剤 |
JPH0612248A (ja) * | 1992-04-02 | 1994-01-21 | Hitachi Ltd | プログラムの自動生成方式 |
-
1993
- 1993-08-12 US US08/211,818 patent/US5464833A/en not_active Expired - Fee Related
- 1993-08-12 CA CA002121148A patent/CA2121148A1/en not_active Abandoned
- 1993-08-12 EP EP94908099A patent/EP0623598A4/en not_active Withdrawn
- 1993-08-12 AU AU47615/93A patent/AU666577B2/en not_active Ceased
- 1993-08-12 WO PCT/JP1993/001144 patent/WO1994004504A1/ja not_active Application Discontinuation
- 1993-08-18 PH PH46711A patent/PH30152A/en unknown
- 1993-08-18 TW TW082106642A patent/TW240168B/zh active
- 1993-08-19 MX MX9305056A patent/MX9305056A/es unknown
-
1995
- 1995-08-29 US US08/520,478 patent/US5691341A/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP0623598A1 (en) | 1994-11-09 |
AU4761593A (en) | 1994-03-15 |
WO1994004504A1 (en) | 1994-03-03 |
US5691341A (en) | 1997-11-25 |
US5464833A (en) | 1995-11-07 |
AU666577B2 (en) | 1996-02-15 |
CA2121148A1 (en) | 1994-03-03 |
TW240168B (ar) | 1995-02-11 |
EP0623598A4 (en) | 1997-05-02 |
MX9305056A (es) | 1994-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH30152A (en) | Apoptosis regulating composition | |
HU9600083D0 (en) | Regulated apoptosis | |
HK1008013A1 (en) | Size composition | |
AU648690B2 (en) | Apoptosis regulator | |
IL106891A (en) | ENR-NR composition | |
GB2268499B (en) | Chipping-resistant composition | |
GB9203474D0 (en) | Novel composition | |
HU9501775D0 (en) | Substituted 6-azaandrostenones | |
HU9501695D0 (en) | Substituted benzazepinones | |
ZA937403B (en) | Substituted carbamoylpyrazolines | |
GB9223133D0 (en) | Composition | |
ZA937442B (en) | Substituted 2-arylpyrroles | |
GB2272222B (en) | Command-curable composition | |
GB9205194D0 (en) | Novel composition | |
GB9218115D0 (en) | Hard composition | |
GB2271999B (en) | Novel composition | |
EP0776359A4 (en) | REGULATED APOPTOSIS | |
GB9219141D0 (en) | Novel composition | |
GB9227073D0 (en) | Replacement composition | |
GB9203272D0 (en) | Composition | |
GB9206677D0 (en) | Composition | |
GB9226689D0 (en) | Detergetn composition | |
GB9215647D0 (en) | Composition | |
GB9302768D0 (en) | Composition | |
GB9206539D0 (en) | Composition |